BMY 44621

structure given in first source

Also Known As:

BMY-44621; 2-Pyrrolidinecarboxamide, N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-1-(1-oxo-3-phenylpropyl)-, (S-(R*,R*))-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Venous Thrombosis (Deep-Vein Thrombosis) 07/01/1994 - "BMY 44621 inhibited arterial and venous thrombosis in a dose-dependent manner. " 07/01/1994 - "A 40% reduction in platelet counts induced by thrombin injection was abolished by the threshold dose of BMY 44621 for inhibiting venous thrombosis. "

1.	Thrombin